NCT04662294
- Conditions
- Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +20 more
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China
Clinical trial condition
Acute Myeloid Leukemia
Explore clinical trials studying Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.
1,002 public trials
282 recruiting studies
Acute Myeloid Leukemia trial results
NCT04167696
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- Mayo Clinic Cancer Center Jacksonville, Florida, United States
- University of Kansas Cancer Center Fairway, Kansas, United States
- Uz Leuven Leuven, Belgium
- Chu Liege Liège, Belgium
Enrolling by Invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
NCT04093570
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
- Locations
-
- Compassionate Care Research Group Fountain Valley, California, United States
- Boca Raton Clinical Research Plantation, Florida, United States
- The University of Chicago Medical Center Chicago, Illinois, United States
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States
Enrolling by Invitation
Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy
NCT07651176
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China
Enrolling by Invitation
Daunorubicin + Cytarabine + Venetoclax in de Novo AML
NCT06697327
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Department of Hematology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road Hefei, Anhui, China
Enrolling by Invitation
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant
NCT04836390
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- AdventHealth Orlando Orlando, Florida, United States
Enrolling by Invitation
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
NCT02646839
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +14 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital Oakland Oakland, California, United States
- Stanford University Medical Center Palo Alto, California, United States
- Rady Children's Hospital San Diego, California, United States
Enrolling by Invitation
A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.
NCT03507842
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea
Enrolling by Invitation
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
NCT05212103
- Conditions
- Acute Myeloid Leukemia, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
- Locations
-
- Turku University Hospital, Turku PET Centre Turku, Finland
Enrolling by Invitation
Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia
NCT05983172
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan